Those IPF patients with the overexpression of DNMT3A or NSUN4 were found to have favorable survival as compared to the rest of the patients, while IPF individuals with elevated NOP2 were found to have poor prognoses (p < .05; Figure 2(b)). The gene discussed is DNMT3A; the disease is idiopathic pulmonary fibrosis.